ID Biomedical Corporation of Quebec – Trademark Portfolio
Entity Type: 03
ID Biomedical Corporation of Quebec holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include FLULAVAL. The owner is based in Laval.
525 Cartier Blvd. West
Laval H7V 3S8 , CA
Showing of trademarks Trademarks
Trademark Classifications
ID Biomedical Corporation of Quebec's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does ID Biomedical Corporation of Quebec have?
ID Biomedical Corporation of Quebec has 12 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 10 abandoned.
What trademark classes does ID Biomedical Corporation of Quebec file in?
ID Biomedical Corporation of Quebec files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ID Biomedical Corporation of Quebec's most well-known trademarks?
ID Biomedical Corporation of Quebec's registered trademark portfolio includes well-known marks such as FLULAVAL. These are among 1 currently registered trademark in the portfolio.
What is ID Biomedical Corporation of Quebec's trademark registration success rate?
ID Biomedical Corporation of Quebec has a 9% trademark registration rate, with 1 out of 11 resolved applications resulting in successful registration. Currently, 1 application is pending review.